2023-03-012024-02-292024-02-29false11846859LABBAIK GLOBAL LTD2024-11-2862020iso4217:GBPxbrli:pure118468592023-03-01118468592024-02-29118468592023-03-012024-02-29118468592022-03-01118468592023-02-28118468592022-03-012023-02-2811846859bus:SmallEntities2023-03-012024-02-2911846859bus:AuditExempt-NoAccountantsReport2023-03-012024-02-2911846859bus:AbridgedAccounts2023-03-012024-02-2911846859bus:PrivateLimitedCompanyLtd2023-03-012024-02-2911846859core:WithinOneYear2024-02-2911846859core:AfterOneYear2024-02-2911846859core:WithinOneYear2023-02-2811846859core:AfterOneYear2023-02-2811846859core:ShareCapital2024-02-2911846859core:SharePremium2024-02-2911846859core:RevaluationReserve2024-02-2911846859core:OtherReservesSubtotal2024-02-2911846859core:RetainedEarningsAccumulatedLosses2024-02-2911846859core:ShareCapital2023-02-2811846859core:SharePremium2023-02-2811846859core:RevaluationReserve2023-02-2811846859core:OtherReservesSubtotal2023-02-2811846859core:RetainedEarningsAccumulatedLosses2023-02-2811846859core:LandBuildings2024-02-2911846859core:PlantMachinery2024-02-2911846859core:Vehicles2024-02-2911846859core:FurnitureFittings2024-02-2911846859core:OfficeEquipment2024-02-2911846859core:NetGoodwill2024-02-2911846859core:IntangibleAssetsOtherThanGoodwill2024-02-2911846859core:ListedExchangeTraded2024-02-2911846859core:UnlistedNon-exchangeTraded2024-02-2911846859core:LandBuildings2023-02-2811846859core:PlantMachinery2023-02-2811846859core:Vehicles2023-02-2811846859core:FurnitureFittings2023-02-2811846859core:OfficeEquipment2023-02-2811846859core:NetGoodwill2023-02-2811846859core:IntangibleAssetsOtherThanGoodwill2023-02-2811846859core:ListedExchangeTraded2023-02-2811846859core:UnlistedNon-exchangeTraded2023-02-2811846859core:LandBuildings2023-03-012024-02-2911846859core:PlantMachinery2023-03-012024-02-2911846859core:Vehicles2023-03-012024-02-2911846859core:FurnitureFittings2023-03-012024-02-2911846859core:OfficeEquipment2023-03-012024-02-2911846859core:NetGoodwill2023-03-012024-02-2911846859core:IntangibleAssetsOtherThanGoodwill2023-03-012024-02-2911846859core:ListedExchangeTraded2023-03-012024-02-2911846859core:UnlistedNon-exchangeTraded2023-03-012024-02-2911846859core:MoreThanFiveYears2023-03-012024-02-2911846859core:Non-currentFinancialInstruments2024-02-2911846859core:Non-currentFinancialInstruments2023-02-2811846859dpl:CostSales2023-03-012024-02-2911846859dpl:DistributionCosts2023-03-012024-02-2911846859core:LandBuildings2023-03-012024-02-2911846859core:PlantMachinery2023-03-012024-02-2911846859core:Vehicles2023-03-012024-02-2911846859core:FurnitureFittings2023-03-012024-02-2911846859core:OfficeEquipment2023-03-012024-02-2911846859dpl:AdministrativeExpenses2023-03-012024-02-2911846859core:NetGoodwill2023-03-012024-02-2911846859core:IntangibleAssetsOtherThanGoodwill2023-03-012024-02-2911846859dpl:GroupUndertakings2023-03-012024-02-2911846859dpl:ParticipatingInterests2023-03-012024-02-2911846859dpl:GroupUndertakingscore:ListedExchangeTraded2023-03-012024-02-2911846859core:ListedExchangeTraded2023-03-012024-02-2911846859dpl:GroupUndertakingscore:UnlistedNon-exchangeTraded2023-03-012024-02-2911846859core:UnlistedNon-exchangeTraded2023-03-012024-02-2911846859dpl:CostSales2022-03-012023-02-2811846859dpl:DistributionCosts2022-03-012023-02-2811846859core:LandBuildings2022-03-012023-02-2811846859core:PlantMachinery2022-03-012023-02-2811846859core:Vehicles2022-03-012023-02-2811846859core:FurnitureFittings2022-03-012023-02-2811846859core:OfficeEquipment2022-03-012023-02-2811846859dpl:AdministrativeExpenses2022-03-012023-02-2811846859core:NetGoodwill2022-03-012023-02-2811846859core:IntangibleAssetsOtherThanGoodwill2022-03-012023-02-2811846859dpl:GroupUndertakings2022-03-012023-02-2811846859dpl:ParticipatingInterests2022-03-012023-02-2811846859dpl:GroupUndertakingscore:ListedExchangeTraded2022-03-012023-02-2811846859core:ListedExchangeTraded2022-03-012023-02-2811846859dpl:GroupUndertakingscore:UnlistedNon-exchangeTraded2022-03-012023-02-2811846859core:UnlistedNon-exchangeTraded2022-03-012023-02-2811846859core:NetGoodwill2024-02-2911846859core:IntangibleAssetsOtherThanGoodwill2024-02-2911846859core:LandBuildings2024-02-2911846859core:PlantMachinery2024-02-2911846859core:Vehicles2024-02-2911846859core:FurnitureFittings2024-02-2911846859core:OfficeEquipment2024-02-2911846859core:AfterOneYear2024-02-2911846859core:WithinOneYear2024-02-2911846859core:ListedExchangeTraded2024-02-2911846859core:UnlistedNon-exchangeTraded2024-02-2911846859core:ShareCapital2024-02-2911846859core:SharePremium2024-02-2911846859core:RevaluationReserve2024-02-2911846859core:OtherReservesSubtotal2024-02-2911846859core:RetainedEarningsAccumulatedLosses2024-02-2911846859core:NetGoodwill2023-02-2811846859core:IntangibleAssetsOtherThanGoodwill2023-02-2811846859core:LandBuildings2023-02-2811846859core:PlantMachinery2023-02-2811846859core:Vehicles2023-02-2811846859core:FurnitureFittings2023-02-2811846859core:OfficeEquipment2023-02-2811846859core:AfterOneYear2023-02-2811846859core:WithinOneYear2023-02-2811846859core:ListedExchangeTraded2023-02-2811846859core:UnlistedNon-exchangeTraded2023-02-2811846859core:ShareCapital2023-02-2811846859core:SharePremium2023-02-2811846859core:RevaluationReserve2023-02-2811846859core:OtherReservesSubtotal2023-02-2811846859core:RetainedEarningsAccumulatedLosses2023-02-2811846859core:NetGoodwill2022-03-0111846859core:IntangibleAssetsOtherThanGoodwill2022-03-0111846859core:LandBuildings2022-03-0111846859core:PlantMachinery2022-03-0111846859core:Vehicles2022-03-0111846859core:FurnitureFittings2022-03-0111846859core:OfficeEquipment2022-03-0111846859core:AfterOneYear2022-03-0111846859core:WithinOneYear2022-03-0111846859core:ListedExchangeTraded2022-03-0111846859core:UnlistedNon-exchangeTraded2022-03-0111846859core:ShareCapital2022-03-0111846859core:SharePremium2022-03-0111846859core:RevaluationReserve2022-03-0111846859core:OtherReservesSubtotal2022-03-0111846859core:RetainedEarningsAccumulatedLosses2022-03-0111846859core:AfterOneYear2023-03-012024-02-2911846859core:WithinOneYear2023-03-012024-02-2911846859core:Non-currentFinancialInstrumentscore:CostValuation2023-03-012024-02-2911846859core:Non-currentFinancialInstrumentscore:AdditionsToInvestments2023-03-012024-02-2911846859core:Non-currentFinancialInstrumentscore:RevaluationsIncreaseDecreaseInInvestments2023-03-012024-02-2911846859core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInInvestments2023-03-012024-02-2911846859core:Non-currentFinancialInstrumentscore:ProvidedReleasedInPeriodProvisionsForImpairmentInvestments2023-03-012024-02-2911846859core:Non-currentFinancialInstrumentscore:ImpairmentLossReversalProvisionsForImpairmentInvestments2023-03-012024-02-2911846859core:Non-currentFinancialInstrumentscore:AcquisitionsIncreaseInProvisionsForImpairmentInvestments2023-03-012024-02-2911846859core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInProvisionsForImpairmentInvestments2023-03-012024-02-2911846859core:Non-currentFinancialInstrumentscore:OtherIncreaseDecreaseInProvisionsForImpairmentInvestments2023-03-012024-02-2911846859core:Non-currentFinancialInstrumentscore:CostValuation2024-02-2911846859core:Non-currentFinancialInstrumentscore:AdditionsToInvestments2024-02-2911846859core:Non-currentFinancialInstrumentscore:RevaluationsIncreaseDecreaseInInvestments2024-02-2911846859core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInInvestments2024-02-2911846859core:Non-currentFinancialInstrumentscore:ProvidedReleasedInPeriodProvisionsForImpairmentInvestments2024-02-2911846859core:Non-currentFinancialInstrumentscore:ImpairmentLossReversalProvisionsForImpairmentInvestments2024-02-2911846859core:Non-currentFinancialInstrumentscore:AcquisitionsIncreaseInProvisionsForImpairmentInvestments2024-02-2911846859core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInProvisionsForImpairmentInvestments2024-02-2911846859core:Non-currentFinancialInstrumentscore:OtherIncreaseDecreaseInProvisionsForImpairmentInvestments2024-02-2911846859core:Non-currentFinancialInstrumentscore:CostValuation2023-02-2811846859core:Non-currentFinancialInstrumentscore:AdditionsToInvestments2023-02-2811846859core:Non-currentFinancialInstrumentscore:RevaluationsIncreaseDecreaseInInvestments2023-02-2811846859core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInInvestments2023-02-2811846859core:Non-currentFinancialInstrumentscore:ProvidedReleasedInPeriodProvisionsForImpairmentInvestments2023-02-2811846859core:Non-currentFinancialInstrumentscore:ImpairmentLossReversalProvisionsForImpairmentInvestments2023-02-2811846859core:Non-currentFinancialInstrumentscore:AcquisitionsIncreaseInProvisionsForImpairmentInvestments2023-02-2811846859core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInProvisionsForImpairmentInvestments2023-02-2811846859core:Non-currentFinancialInstrumentscore:OtherIncreaseDecreaseInProvisionsForImpairmentInvestments2023-02-2811846859bus:Director12023-03-012024-02-2911846859bus:Director22023-03-012024-02-29

LABBAIK GLOBAL LTD

Registered Number
11846859
(England and Wales)

Unaudited Financial Statements for the Year ended
29 February 2024

LABBAIK GLOBAL LTD
Company Information
for the year from 1 March 2023 to 29 February 2024

Directors

Yasser Alkhouli
Behnaz Rayati

Registered Address

71-75 Uxbridge Road
London
W5 5SL

Registered Number

11846859 (England and Wales)
LABBAIK GLOBAL LTD
Balance Sheet as at
29 February 2024

Notes

2024

2023

£

£

£

£

Fixed assets
Tangible assets36561,531
6561,531
Current assets
Debtors436,91228,487
Cash at bank and on hand1,87723,417
38,78951,904
Creditors amounts falling due within one year5(9,561)(12,599)
Net current assets (liabilities)29,22839,305
Total assets less current liabilities29,88440,836
Creditors amounts falling due after one year(30,833)(40,833)
Net assets(949)3
Capital and reserves
Called up share capital22
Profit and loss account(951)1
Shareholders' funds(949)3
The financial statements were approved and authorised for issue by the Board of Directors on 28 November 2024, and are signed on its behalf by:
Yasser Alkhouli
Director
Registered Company No. 11846859
LABBAIK GLOBAL LTD
Notes to the Financial Statements
for the year ended 29 February 2024

1.Accounting policies
Statutory information
The company is a private company limited by shares and registered in England and Wales. The company's registered number and registered office address can be found on the Company Information page.
Statement of compliance
The financial statements have been prepared in compliance with FRS 102 Section 1A as it applies to the financial statements for the period and there were no material departures from the reporting standard.
Revenue from sale of goods
Turnover from the sale of goods is recognised when the significant risks and rewards of ownership of the goods have transferred to the buyer. Turnover from the rendering of services is recognised by reference to the stage of completion of the contract. The stage of completion of a contract is measured by comparing the costs incurred for work performed to date to the total estimated contract costs.
Employee benefits
Contributions to defined contribution plans are expensed in the period to which they relate.
Foreign currency translation
Transactions in foreign currencies are initially recognised at the rate of exchange ruling at the date of the transaction. At the end of each reporting period foreign currency monetary items are translated at the closing rate of exchange. Non-monetary items that are measured at historical cost are translated at the rate ruling at the date of the transaction. All differences are charged to profit or loss.
Tangible fixed assets and depreciation
Tangible fixed assets are stated at cost or valuation less depreciation. Depreciation is provided on all tangible fixed assets as follows:

Straight line (years)
Office Equipment4
2.Average number of employees

20242023
Average number of employees during the year22
3.Tangible fixed assets

Total

£
Cost or valuation
At 01 March 233,500
At 29 February 243,500
Depreciation and impairment
At 01 March 231,969
Charge for year875
At 29 February 242,844
Net book value
At 29 February 24656
At 28 February 231,531
4.Debtors: amounts due within one year

2024

2023

££
Trade debtors / trade receivables163-
Amounts owed by associates and joint ventures / participating interests31,05122,474
Other debtors5,4625,777
Prepayments and accrued income236236
Total36,91228,487
Short term debtors are measured at transaction price (which is usually the invoice price), less any impairment losses for bad and doubtful debts. Loans and other financial assets are initially recognised at transaction price including any transaction costs and subsequently measured at amortised cost determined using the effective interest method, less any impairment losses for bad and doubtful debts.
5.Creditors: amounts due within one year

2024

2023

££
Trade creditors / trade payables8773,874
Taxation and social security6,1845,470
Other creditors-3,255
Accrued liabilities and deferred income2,500-
Total9,56112,599
Short term creditors are measured at transaction price (which is usually the invoice price). Loans and other financial liabilities are initially recognised at transaction price net of any transaction costs and subsequently measured at amortised cost determined using the effective interest method.